Kit for simultaneous detection of mRNA of chimeric transcripts BCR::ABL (transcripts b2a2, b3a2), PML::RARa (transcripts bcr 1,2,3), CBFB::MYH11 (transcripts A,D, E) and RUNX1-RUNX1T1. The study is carried out in clinical material by the method of polymerase chain reaction (PCR) with hybridization-fluorescence detection in the "real time" mode.

The reagent kit can be used for the primary diagnosis of patients with acute myeloid leukemia in order to identify informative markers of relapse and minimal residual disease.

The reagent kit is designed to conduct a study for 24 clinical samples in duplicate and to present the results in qualitative format.

Ordering information:

AML MultiPrime Screen Kit, 24 tests                                                     Cat.no  R-3-24

Additiional reagents:

TriZ Reagent RNA Kit                                                                               Cat.no  TRK-100

ReverZyme Kit                                                                                          Cat.No RT-1

Price: on request 

Reagents are for research use only (RUO)